Editas Medicine, Inc.

Direct answer

Editas Medicine, Inc. is publicly traded on NASDAQ under the ticker EDIT.

Editas Medicine, Inc. is a leading biotechnology firm focused on clinical-stage genome editing, with a primary mission to pioneer groundbreaking genetic therapies designed to address a wide array of severe medical conditions. The company leverages a unique, in-house developed gene editing platform that utilizes cutting-edge CRISPR technology. Editas's pipeline features several promising candidates, including...

Can you invest in Editas Medicine, Inc.?

Yes. Editas Medicine, Inc. is publicly traded on NASDAQ under the ticker EDIT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Editas Medicine, Inc.

Detailed equity research is provided by MarketSnap.